ADJUVANT THERAPY WITH ISOCARBOXAZID
Abstract
In this series of 47 patients with a variety of depressive reactions, isocarboxazid produced a fair to excellent effect in 63.8% overall, and in 26 of the 27 reactive depressives and schizophrenic apathetics. Although it did not eliminate nor reduce the need for ECT, it was a valuable adjunct to ECT and intensive psychotherapy, particularly in reactive depressions. While not found quite as effective as iproniazid, it was definitely better tolerated and less toxic, with no clinical evidence of hepatoxicity in any of the patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
